Laura Dodd

Associate Director of Clinical Trial Transparency & Disclosure at Kura Oncology

Speaker

Laura Dodd serves as Associate Director of Clinical Trial Transparency and Disclosure at Kura Oncology, where she helps colleagues understand the complex and ever-changing world of global clinical trial regulations. She has extensive experience in document anonymization, including managing large-scale projects and supporting regulatory submissions under EMA Policy 0070 and Health Canada PRCI. Having worked across CROs, large pharma, and small biotech companies, Laura brings a grounded, real-world perspective on how organizations can meet transparency requirements while protecting sensitive information.